Literature DB >> 22785217

Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.

Hatem A Azim1, Luigi Santoro, William Russell-Edu, George Pentheroudakis, Nicholas Pavlidis, Fedro A Peccatori.   

Abstract

BACKGROUND: Pregnancy-associated breast cancer (PABC) is relatively rare with considerable controversy regarding its prognosis. PATIENTS &
METHODS: Two of the authors independently performed a literature search with no date or language restrictions. Eligible studies were control-matched, population-based and hospital-based studies that addressed the outcome of patients diagnosed during pregnancy or 1-year afterwards. The primary and secondary end-points were overall and disease-free survival respectively. Pooling of data was done using the random effect model.
RESULTS: 30 studies were included in this meta-analysis (3,628 cases and 37,100 controls). PABC patients had a significantly higher risk of death compared to those with non-pregnancy-related breast cancer (pooled hazard ratio (pHR): 1.44; 95% CI [1.27-1.63]). The same results were encountered on restricting the analysis to HRs of multivariate analyses (pHR: 1.40 [1.17-1.67]). A clearer trend of poorer outcome was seen in those diagnosed postpartum (pHR: 1.84; 95% CI [1.28-2.65]) than those diagnosed during pregnancy (pHR: 1.29; 95% CI [0.74-2.24]). DFS analysis showed a significantly higher risk of relapse associated with PABC as well (pHR: 1.60 [1.19-2.16]).
CONCLUSION: Our results show that PABC is independently associated with poor survival particularly those diagnosed shortly post-partum. This underscores a possible impact of the pregnant breast microenvironment on the biology and consequently the prognosis of these tumors.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22785217     DOI: 10.1016/j.ctrv.2012.06.004

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  52 in total

1.  Challenges in managing breast cancer during pregnancy.

Authors:  Flora Zagouri; Theodora Psaltopoulou; Constantine Dimitrakakis; Rupert Bartsch; Meletios-Athanassios Dimopoulos
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period.

Authors:  Ciara C O'Sullivan; Sheeba Irshad; Zheyu Wang; Zhuojun Tang; Christopher Umbricht; Gary L Rosner; Mindy S Christianson; Vered Stearns; Karen Lisa Smith
Journal:  Breast Cancer Res Treat       Date:  2020-03-11       Impact factor: 4.872

Review 3.  Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature.

Authors:  J Raphael; M E Trudeau; K Chan
Journal:  Curr Oncol       Date:  2015-03       Impact factor: 3.677

Review 4.  Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments?

Authors:  Virginia F Borges; Traci R Lyons; Doris Germain; Pepper Schedin
Journal:  Cancer Res       Date:  2020-02-19       Impact factor: 12.701

5.  Pregnancy-associated breast cancer: clinicopathological characteristics of 20 cases with a focus on identifiable causes of diagnostic delay.

Authors:  Derman Basaran; Mert Turgal; Kemal Beksac; Ozgur Ozyuncu; Omer Aran; M Sinan Beksac
Journal:  Breast Care (Basel)       Date:  2014-10       Impact factor: 2.860

6.  Clinicopathological features and prognosis of pregnancy associated breast cancer - a matched case control study.

Authors:  Lilla Madaras; Kristóf Attila Kovács; Attila Marcell Szász; István Kenessey; Anna-Mária Tőkés; Borbála Székely; Zsuzsanna Baranyák; Orsolya Kiss; Magdolna Dank; Janina Kulka
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

7.  Incidence and Survival by Human Epidermal Growth Factor Receptor 2 Status in Young Women With Stage I-III Breast Cancer: SEER, 2010-2016.

Authors:  Alexandra Thomas; Anthony Rhoads; Jonathan Suhl; Kristin M Conway; William G Hundley; Lacey R McNally; Jacob Oleson; Susan A Melin; Charles F Lynch; Paul A Romitti
Journal:  Clin Breast Cancer       Date:  2020-02-04       Impact factor: 3.225

8.  Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study.

Authors:  Ningqi Hou; Temidayo Ogundiran; Oladosu Ojengbede; Imran Morhason-Bello; Yonglan Zheng; James Fackenthal; Clement Adebamowo; Imaria Anetor; Stella Akinleye; Olufunmilayo I Olopade; Dezheng Huo
Journal:  Ann Epidemiol       Date:  2013-07-20       Impact factor: 3.797

Review 9.  Heightened susceptibility: A review of how pregnancy and chemical exposures influence maternal health.

Authors:  Julia Varshavsky; Anna Smith; Aolin Wang; Elizabeth Hom; Monika Izano; Hongtai Huang; Amy Padula; Tracey J Woodruff
Journal:  Reprod Toxicol       Date:  2019-05-02       Impact factor: 3.143

10.  Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study.

Authors:  Lisa Prior; Richard O'Dwyer; Abdul Rehman Farooq; Megan Greally; Cian Ward; Connor O'Leary; Razia Aslam; Waseem Darwish; Nada Ahmed; Elly Che Othman; Geoffrey Watson; Deirdre Kelly; Jack Gleeson; Lisa Kiely; Anees Hassan; Elaine M Walsh; David O'Reilly; Alfred Jones; Hannah Featherstone; Marvin Lim; Hazel Murray; Bryan T Hennessy; Lillian M Smyth; Gregory Leonard; Liam Grogan; Oscar Breathnach; Paula Calvert; Anne M Horgan; Linda Coate; Emmet J Jordan; Deirdre O'Mahony; Rajnish Gupta; Maccon M Keane; Jennifer Westrup; Karen Duffy; Miriam O'Connor; Patrick G Morris; M John Kennedy; Seamus O'Reilly; John McCaffrey; Catherine M Kelly; Desmond Carney; Giuseppe Gullo; John Crown; Michaela J Higgins; Paul M Walsh; Janice M Walshe
Journal:  Breast Cancer Res Treat       Date:  2021-06-14       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.